High-dose ifosfamide with mesna and granulocyte-colony-stimulating factor (recombinant human G-CSF) in patients with unresectable malignant mesothelioma.

MLA

Talbot, Susan M., et al. “High-Dose Ifosfamide with Mesna and Granulocyte-Colony-Stimulating Factor (Recombinant Human G-CSF) in Patients with Unresectable Malignant Mesothelioma.” Cancer, vol. 98, no. 2, July 2003, pp. 331–36. EBSCOhost, https://doi.org/10.1002/cncr.11512.

APA

Talbot, S. M., Rankin, C., Taub, R. N., Balcerzak, S. P., Jr, Bhoopalam, N., Chapman, R. A., Baker, L. H., Middleman, E. L., & Antman, K. H. (2003). High-dose ifosfamide with mesna and granulocyte-colony-stimulating factor (recombinant human G-CSF) in patients with unresectable malignant mesothelioma. Cancer, 98(2), 331–336. https://doi.org/10.1002/cncr.11512

Chicago

Talbot, Susan M, Cathryn Rankin, Robert N Taub, Stanley P Balcerzak Jr, Nirmala Bhoopalam, Robert A Chapman, Laurence H Baker, Edward L Middleman, and Karen H Antman. 2003. “High-Dose Ifosfamide with Mesna and Granulocyte-Colony-Stimulating Factor (Recombinant Human G-CSF) in Patients with Unresectable Malignant Mesothelioma.” Cancer 98 (2): 331–36. doi:10.1002/cncr.11512.